Romero-Zerbo, Silvana Y <br/><br/>
The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.  [electronic resource] 

 -  Frontiers in endocrinology  2020 
 - 103 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1664-2392 
<br/><br/><label>Standard No.: </label>10.3389/fendo.2020.00103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--drug effects<br/>Animals<br/>Cytoprotection--drug effects<br/>Diet, High-Fat<br/>Disease Models, Animal<br/>Inflammation--etiology<br/>Liver--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Obese<br/>Non-alcoholic Fatty Liver Disease--drug therapy<br/>Obesity--complications<br/>Pancreas--drug effects<br/>Prediabetic State--drug therapy<br/>Resorcinols--pharmacology